Sarepta Therapeutics, Inc. — Director's Dealing 2017

Sep 26, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2017-09-25

Reporting Person: Basi Guriqbal S. (SVP, Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-25	Stock Option (right to buy)	$43.90	A	100000	Acquired	2027-09-25	Common Stock (100000)	Direct

Footnotes

F1: 25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.